{
    "clinical_study": {
        "@rank": "58820", 
        "arm_group": [
            {
                "arm_group_label": "Shinbaro (only)"
            }, 
            {
                "arm_group_label": "Celecoxib (only)"
            }, 
            {
                "arm_group_label": "Shinbaro + NSAIDs"
            }, 
            {
                "arm_group_label": "Shinbaro + Celecoxib"
            }
        ], 
        "brief_summary": {
            "textblock": "This study investigates how gastrointestinal toxicity affects discontinuation of medication\n      given to patients with osteoarthritis in routine clinical practice."
        }, 
        "brief_title": "A Prospective Observational Study on Discontinuation of Medication of Shinbaro Capsule", 
        "completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Osteoarthritis", 
        "condition_browse": {
            "mesh_term": "Osteoarthritis"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Minimum 20- year-old patients diagnosed with osteoarthritis\n\n          -  Within 2 weeks prior to participation, not taken anti-inflammatory analgesic drug\n             such as the Shinbaro Capsule, Celecoxib Capsule and NSAIDs(non-steroidal\n             anti-inflammatory drugs)\n\n          -  Written consent form voluntarity\n\n        Exclusion Criteria:\n\n          -  Diagnosed with disease that may affect measurement of efficacy clinically\n\n          -  Diagnosed with clinically significant phycological disorder, and taking medication\n\n          -  Participated in a clinical trial within 4 weeks\n\n          -  Pregnant or lactating woman\n\n          -  History of malignant disease within the previous 5 years\n\n          -  Patients who seem not to participate in the study at investigator's discretion"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "20 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Patients with osteoarthritis being treated with anti-inflammatory analgesic drug at\n        general hospitals and clinics in South Korea"
            }
        }, 
        "enrollment": {
            "#text": "6700", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 12, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02064634", 
            "org_study_id": "GCSB_OS"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Anti-Inflammatory Agents, Non-Steroidal", 
                "Celecoxib"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Shinbaro Capsule", 
            "Celecoxib", 
            "Osteoarthritis", 
            "GCSB-5", 
            "Discontinuation rate", 
            "Gastrointestinal adverse event", 
            "NSAIDs"
        ], 
        "lastchanged_date": "March 26, 2014", 
        "location": {
            "contact": {
                "email": "jepark@greencross.com", 
                "last_name": "Jeong Eun Park"
            }, 
            "facility": {
                "address": {
                    "city": "Yongin-si", 
                    "country": "Korea, Republic of", 
                    "state": "Gyeonggi-do", 
                    "zip": "446-770"
                }, 
                "name": "Green Cross Corporation"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_groups": "4", 
        "official_title": "A Multicenter, Comparative, Open Label, Prospective Observational Study on Discontinuation of Medication Due to Gastrointestinal Adverse Effects for the Patients Being Treated for Osteoarthritis With Anti-inflammatory Analgesic Drug", 
        "overall_contact": {
            "email": "jepark@greencross.com", 
            "last_name": "Jeong Eun Park"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Korea: Ministry of Food and Drug Safety", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Discontinuation rate due to gastrointestinal adverse effects", 
            "safety_issue": "Yes", 
            "time_frame": "up to 12 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02064634"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Number of participants discontinued from medication due to lack of efficacy", 
                "measure": "Rate of medication discontinuation recorded as lack of efficacy", 
                "safety_issue": "No", 
                "time_frame": "up to 12 weeks"
            }, 
            {
                "description": "Number of participants discontinued from medication", 
                "measure": "Rate of medication discontinuation", 
                "safety_issue": "Yes", 
                "time_frame": "up to 12 weeks"
            }, 
            {
                "measure": "Discontinuation rate due to adverse events", 
                "safety_issue": "Yes", 
                "time_frame": "up to 12 weeks"
            }
        ], 
        "source": "Green Cross Corporation", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Green Cross Corporation", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "February 2014", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "February 2014"
    }
}